LYOPHILIZED PHARMACEUTICAL COMPOSITIONS OF DALBAVANCIN
A lyophilized pharmaceutical composition comprising: a) dalbavancin hydrochloride or its pharmaceutically acceptable salt; b) a pharmaceutically acceptable amount of amino acid as stabilizer) the ratio of dalvabancin to stabilizer is 1:0.8 to 1:1 by weight, d) said formulation has a pH in the range...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
09.12.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A lyophilized pharmaceutical composition comprising: a) dalbavancin hydrochloride or its pharmaceutically acceptable salt; b) a pharmaceutically acceptable amount of amino acid as stabilizer) the ratio of dalvabancin to stabilizer is 1:0.8 to 1:1 by weight, d) said formulation has a pH in the range of 5.1-6 v) said formulation contains no more than about 1% MAG by weight after 3 Months at 40°C and 75 % RH. |
---|---|
Bibliography: | Application Number: EP20170873284 |